Gregory M Lanza

USPTO Granted Patents = 40 (Patent Applications = 4)

CIPO Patents = 4 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.7

ph-index = 10

Forward Citations = 574(Granted Patents)

Location History:

Kirkwood, MO (US) (1986)
Evanston, IL (US) (1997)
Creve Coeur, MO (US) (1999)
St. Louis, MO (US) (1997 - 2024)

Company Filing History:

18 out of 36

Barnes Jewish Hospital

patents

16 out of 1,586

Washington University

patents

3 out of 12

Bristol-myers Squibb Medical Imaging, Inc.

patents

4. 2 out of 2,119

Northwestern University

patents

5. 2 out of 7,680

The Dow Chemical Company

patents

6. 1 out of 7

The Jewish Hospital of St. Louis

patents

7. 1 out of 21,384

Koninklijke Philips Corporation N.V.

where one patent can have more than one assignee

Years Active: 1986-2024

Loading Chart...

Areas of Expertise:

Prodrug Compositions

Nanoparticle Delivery Systems

Targeted Drug Delivery

Blood Substitute Composition

Homing Agents

Integrin Targeted Imaging Agents

Paramagnetic Particles

Spectral Imaging

Ligand Directed Nanoparticles

Enhanced Ultrasound Detection

Acoustically Reflective Liposomes

Avidin-Biotin Conjugated Emulsions

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11872313 - Prodrug compositions, prodrug nanoparticles, and methods of use thereof (2024-01-16),

2. 11141379 - Prodrug compositions, prodrug nanoparticles, and methods of use thereof (2021-10-12),

3. 11052163 - Homing agents (2021-07-06),

4. 10201500 - Prodrug compositions, prodrug nanoparticles, and methods of use thereof (2019-02-12),

5. 9928585 - Spectral imaging (2018-03-27),

6. 9849201 - Homing agents (2017-12-26),

7. 9750241 - Blood substitute composition and method of use (2017-09-05),

8. 9655952 - Blood substitute composition and method of use (2017-05-23),

9. 9498439 - Prodrug compositions, prodrug nanoparticles, and methods of use thereof (2016-11-22),

10. 9486508 - Blood substitute composition and method of use (2016-11-08),

11. 9468607 - Ligand directed toroidal nanoparticles for therapy and diagnostic imaging (2016-10-18),

12. 9446150 - Particles for imaging (2016-09-20),

13. 9415018 - Methods for improving muscle strength (2016-08-16),

14. 9095521 - Methods for improving muscle strength (2015-08-04),

15. 8617516 - Universal anchor peptide for nanoparticles (2013-12-31),

Title: The Innovations of Gregory M Lanza

Introduction

Gregory M Lanza is a prominent inventor based in St. Louis, Missouri, known for his significant contributions to the field of medicine and drug delivery systems. With an impressive portfolio of 37 patents, Lanza has developed innovative techniques and compositions that enhance the effectiveness of pharmaceuticals. His work has had a substantial impact on both research and clinical applications.

Latest Patents

Among Lanza's latest innovations are patent applications focusing on prodrug compositions and prodrug nanoparticles. The essence of these inventions lies in their ability to optimize drug delivery. The present invention encompasses prodrug compositions, nanoparticles comprising one or more prodrugs, and methods of use thereof. This innovative approach can lead to more efficient treatments and improved patient outcomes.

Career Highlights

Throughout his career, Gregory M Lanza has been associated with renowned institutions such as Barnes Jewish Hospital and Washington University. His work in these establishments has fostered an environment that promotes cutting-edge research and clinical application of his inventions, further advancing the field of medicine.

Collaborations

Lanza's contributions have been enhanced through collaborations with notable colleagues, including Samuel A. Wickline and Dipanjan Pan. These partnerships have allowed him to expand the scope and effectiveness of his research, resulting in groundbreaking advancements in drug delivery systems.

Conclusion

Gregory M Lanza continues to be a pivotal figure in scientific innovation. His prolific patent portfolio and collaborative spirit demonstrate his commitment to advancing medical technology. As his research progresses, Lanza's inventions are likely to play a crucial role in shaping the future of drug delivery and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.